The clinical evaluation of 5-fluoro-2'-deoxyuridine in acute leukemia in children. 1960

J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine

Related Publications

J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
July 1962, Cancer chemotherapy reports,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
November 1967, Cancer research,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
February 1960, Cancer chemotherapy reports,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
February 1960, Cancer chemotherapy reports,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
September 1974, Journal of medicinal chemistry,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
May 1988, Proceedings of the National Academy of Sciences of the United States of America,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
January 1990, Anticancer research,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
January 1966, Journal of medicinal chemistry,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
May 1993, Journal of medicinal chemistry,
J R HARTMANN, and M ERLANDSON, and M L MURPHY, and M L ORIGENES, and A SITARZ
November 1978, Cancer research,
Copied contents to your clipboard!